Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets

References

• Yanagi S, Inatome R, Takano T, Yamamura H. Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun. 2001;288(3):495–7. doi:10.1006/bbrc.2001.5788.
   PubMed Web of Science ®Google Scholar
• Tsygankov AY. Non-receptor protein tyrosine kinases. Front Biosci. 2003;8(6):s595–635. doi:10.2741/1106.
   PubMedGoogle Scholar
• Geahlen RL. Syk and pTyr’d: signaling through the B cell antigen receptor. Biochim Biophys Acta. 2009;1793(7):1115–27. doi:10.1016/j.bbamcr.2009.03.004.
   PubMed Web of Science ®Google Scholar
• Mocsai A, Ruland J, Tybulewicz VL. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010;10(6):387–402. doi:10.1038/nri2765.
   PubMed Web of Science ®Google Scholar
• Bhavaraju K, Kim S, Daniel JL, Kunapuli SP. Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets. Eur J Pharmacol. 2008;580(3):285–90. doi:10.1016/j.ejphar.2007.11.009.
   PubMed Web of Science ®Google Scholar
• Poole A, Gibbins JM, Turner M, van Vugt MJ, van de Winkel JG, Saito T, Tybulewicz VL, Watson SP. The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 1997;16(9):2333–41. doi:10.1093/emboj/16.9.2333.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Wilde JI, Andrews RK, Auger JM, Siraganian RP, Sekiya F, Rhee SG, Watson SP. Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sites. Biochem J. 2004;378(3):1023–9. doi:10.1042/bj20031430.
   PubMedGoogle Scholar
• Watson AA, Christou CM, James JR, Fenton-May AE, Moncayo GE, Mistry AR, Davis SJ, Gilbert RJ, Chakera A, O’Callaghan CA. The platelet receptor CLEC-2 is active as a dimer. Biochemistry. 2009;48(46):10988–96. doi:10.1021/bi901427d.
   PubMed Web of Science ®Google Scholar
• Coopman PJ, Mueller SC. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett. 2006;241(2):159–73. doi:10.1016/j.canlet.2005.11.004.
   PubMed Web of Science ®Google Scholar
• Hong J, Yuan Y, Wang J, Liao Y, Zou R, Zhu C, Li B, Liang Y, Huang P, Wang Z, et al. Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma. Cancer Res. 2014;74(6):1845–56. doi:10.1158/0008-5472.CAN-13-2104.
   PubMed Web of Science ®Google Scholar
• Coebergh van den Braak RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, Bril SI, van Galen A, Smid M, Biermann K, van Krieken J, Kloosterman WP, et al. High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients. PLoS One. 2017;12(9):e0185607. doi:10.1371/journal.pone.0185607.
   PubMed Web of Science ®Google Scholar
• Prinos P, Garneau D, Lucier JF, Gendron D, Couture S, Boivin M, Brosseau JP, Lapointe E, Thibault P, Durand M, et al. Alternative splicing of SYK regulates mitosis and cell survival. Nat Struct Mol Biol. 2011;18(6):673–9. doi:10.1038/nsmb.2040.
   PubMed Web of Science ®Google Scholar
• Ni B, Hu J, Chen D, Li L, Chen D, Wang J, Wang L. Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression. Oncol Lett. 2016;12(3):1737–44. doi:10.3892/ol.2016.4858.
   PubMed Web of Science ®Google Scholar
• Denis V, Cassagnard N, Del Rio M, Cornillot E, Bec N, Larroque C, Jeanson L, Jarlier M, Combes E, Robert B, et al. Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells. PLoS One. 2022;17(9):e0274390. doi:10.1371/journal.pone.0274390.
   PubMed Web of Science ®Google Scholar
• Rao N, Ghosh AK, Ota S, Zhou P, Reddi AL, Hakezi K, Druker BK, Wu J, Band H. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J. 2001;20:7085–95. doi:10.1093/emboj/20.24.7085.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Carpino N, Tsygankov A. TULA proteins regulate activity of the protein tyrosine kinase Syk. J Cell Biochem. 2008;104(3):953–64. doi:10.1002/jcb.21678.
   PubMed Web of Science ®Google Scholar
• Chen X, Ren L, Kim S, Carpino N, Daniel JL, Kunapuli SP, Tsygankov AY, Pei D. Determination of the substrate specificity of protein-tyrosine phosphatase TULA-2 and identification of Syk as a TULA-2 substrate. J Biol Chem. 2010;285(41):31268–76. doi:10.1074/jbc.M110.114181.
   PubMed Web of Science ®Google Scholar
• Rowley RB, Bolen JB, Fargnoli J. Molecular cloning of rodent p72Syk. Evidence of alternative mRNA splicing. J Biol Chem. 1995;270(21):12659–64. doi:10.1074/jbc.270.21.12659.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Kairiyama L, Araki M, Nagasawa S. Evidence for involvement of two isoforms of Syk protein-tyrosine kinase in signal transduction through the high affinity IgE receptor on rat basophilic leukemia cells. J Biochem (Tokyo). 1998;123(6):1199–207. doi:10.1093/oxfordjournals.jbchem.a022061.
   PubMed Web of Science ®Google Scholar
• Duta F, Ulanova M, Seidel D, Puttagunta L, Musat-Marcu S, Harrod KS, Schreiber AD, Steinhoff U, Befus AD. Differential expression of spleen tyrosine kinase Syk isoforms in tissues: effects of the microbial flora. Histochem Cell Biol. 2006;126(4):495–505. doi:10.1007/s00418-006-0188-z.
   PubMed Web of Science ®Google Scholar
• Wang L, Duke L, Zhang PS, Arlinghaus RB, Symmans WF, Sahin A, Mendez R, Dai JL. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res. 2003;63:4724–30.
   PubMed Web of Science ®Google Scholar
• Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73–82. doi:10.1182/blood-2012-04-416594.
   PubMed Web of Science ®Google Scholar
• Zeiler M, Moser M, Mann M. Copy number analysis of the murine platelet proteome spanning the complete abundance range. Mol Cell Proteomics. 2014;13(12):3435–45. doi:10.1074/mcp.M114.038513.
   PubMed Web of Science ®Google Scholar
• Latour S, Zhang J, Siraganian RP, Veillette A. A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling. EMBO J. 1998;17:2584–95. doi:10.1093/emboj/17.9.2584.
   PubMed Web of Science ®Google Scholar
• Latour S, Chow LM, Veillette A. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. J Biol Chem. 1996;271(37):22782–90. doi:10.1074/jbc.271.37.22782.
   PubMed Web of Science ®Google Scholar
• Hunter S, Sato N, Kim MK, Huang ZY, Chu DH, Park JG, Schreiber AD. Structural requirements of Syk kinase for Fcγ receptor– phagocytosis. Exp Hematol. 1999;27(5):875–84. doi:10.1016/S0301-472X(99)00025-9.
   PubMed Web of Science ®Google Scholar
• Zahedi RP, Lewandrowski U, Wiesner J, Wortelkamp S, Moebius J, Schutz C, Walter U, Gambaryan S, Sickmann A. Phosphoproteome of resting human platelets. J Proteome Res. 2008;7(2):526–34. doi:10.1021/pr0704130.
   PubMed Web of Science ®Google Scholar
• Beck F, Geiger J, Gambaryan S, Solari FA, Dell’aica M, Loroch S, Mattheij NJ, Mindukshev I, Potz O, Jurk K, et al. Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood. 2017;129(2):e1–e12. doi:10.1182/blood-2016-05-714048.
   PubMed Web of Science ®Google Scholar
• Bohnenberger H, Oellerich T, Engelke M, Hsiao HH, Urlaub H, Wienands J. Complex phosphorylation dynamics control the composition of the Syk interactome in B cells. Eur J Immunol. 2011;41(6):1550–62. doi:10.1002/eji.201041326.
   PubMed Web of Science ®Google Scholar
• Paris LL, Hu J, Galan J, Ong SS, Martin VA, Ma H, Tao WA, Harrison ML, Geahlen RL. Regulation of Syk by phosphorylation on serine in the linker insert. J Biol Chem. 2010;285(51):39844–54. doi:10.1074/jbc.M110.164509.
   PubMed Web of Science ®Google Scholar
• Makhoul S, Dorschel S, Gambaryan S, Walter U, Jurk K. Feedback regulation of Syk by protein kinase C in human platelets. Int J Mol Sci. 2019;21(1):21. doi:10.3390/ijms21010176.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Abraham S, Andre P, Edelstein LC, Shaw CA, Dangelmaier CA, Tsygankov AY, Kunapuli SP, Bray PF, McKenzie SE. Anti–miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice. Blood. 2015;126(26):2871–81. doi:10.1182/blood-2015-02-631135.
   PubMed Web of Science ®Google Scholar
• Dunster JL, Unsworth AJ, Bye AP, Haining EJ, Sowa MA, Di Y, Sage T, Pallini C, Pike JA, Hardy AT, et al. Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation. J Thromb Haemost. 2020;18(2):485–96. doi:10.1111/jth.14673.
   PubMed Web of Science ®Google Scholar
• Schweighoffer E, Nys J, Vanes L, Smithers N, Tybulewicz VLJ. TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. J Exp Med. 2017;214(5):1269–80. doi:10.1084/jem.20161117.
   PubMed Web of Science ®Google Scholar
• Ali MF, Driscoll CB, Walters PR, Limper AH, Carmona. β-Glucan–activated human B Lymphocytes participate in innate immune responses by releasing proinflammatory cytokines and stimulating neutrophil chemotaxis. J Immunol. 2015;195(11):5318–26. doi:10.4049/jimmunol.1500559.
   PubMed Web of Science ®Google Scholar
• Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol. 2008;28(3):s17–24. doi:10.1161/ATVBAHA.107.160218.
   PubMed Web of Science ®Google Scholar
• Nassa G, Giurato G, Cimmino G, Rizzo F, Ravo M, Salvati A, Nyman TA, Zhu Y, Vesterlund M, Lehtio J, et al. Splicing of platelet resident pre-mRnas upon activation by physiological stimuli results in functionally relevant proteome modifications. Sci Rep. 2018;8(1):498. doi:10.1038/s41598-017-18985-5.
   PubMedGoogle Scholar
• Reppschlager K, Gosselin J, Dangelmaier CA, Thomas DH, Carpino N, McKenzie SE, Kunapuli SP, Tsygankov AY. TULA-2 protein phosphatase suppresses activation of Syk through the GPVI platelet receptor for collagen by dephosphorylating Tyr(P)346, a regulatory site of Syk. J Biol Chem. 2016;291(43):22427–41. doi:10.1074/jbc.M116.743732.
   PubMed Web of Science ®Google Scholar